NINLARO

Identification of Ninlaro

No description

Google image searchProduct monograph

Active ingredient

ixazomib (ixazomib citrate), 2.3 MG

DIN: 02456796

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: TAKEDA CANADA INC

Date: 21-SEP-2016

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
• L01XG — Proteasome inhibitors (ATC, ATC/DDD)
• L01XG03 — IXAZOMIB (ATC/DDD)

External Links for Ninlaro

Search on Google

• Ninlaro side effects
• Ninlaro dosage
• ixazomib side effects
• ixazomib dosage

Takeda Canada Inc

Go to Takeda website to see drug product details. Sometimes you can find ninlaro photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.